Ocular toxoplasmosis: Clinical features and prognosis of 154 patients

Ophthalmology

Volumn 109, Issue 5, 2002, Pages 869-878

  Bosch Driessen, Lotje E H ^a   Berendschot, Tos T J M ^a   Ongkosuwito, Jenny V ^a   Rothova, Aniki ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CONGENITAL INFECTION; EYE INFLAMMATION; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RETINA INJURY; RISK FACTOR; TOXOPLASMOSIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPROTOZOAL AGENTS; BLINDNESS; CHILD; CHILD, PRESCHOOL; CHOROID DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETINAL DISEASES; RETROSPECTIVE STUDIES; TOXOPLASMOSIS, OCULAR; VISUAL ACUITY;

EID: 0036239023     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)00990-9     Document Type: Article

References (57)

1. Present status of clinical manifestations of toxoplasmosis in man
2. Toxoplasma chorioretinitis in adults
3. Toxoplasmosis in the adult
4. Ocular toxoplasmosis in adult patients
5. Variations in recurrent active toxoplasmic retinochoroiditis
6. Toxoplasmosis
7. Recurrent ocular disease in postnatally acquired toxoplasmosis
8. Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection
9. Prevalence of toxoplasma antibodies according to age with comments on the risk of prenatal infection
10. Aqueous humor analysis as a diagnostic tool in toxoplasma uveitis
11. Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis
12. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis
13. Comparison of PCR detection methods for B1, P30, and 18S rDNA genes of T. gondii in aqueous humor
14. Leading causes of visual impairment worldwide
15. The World Health Organization categories of visual impairment
16. Global data on blindness
17. Treatment of toxoplasmosis uveitis
18. Manifestations and management of ocular toxoplasmosis
19. Clindamycin in the treatment of human ocular toxoplasmosis
20. Clindamycin in the treatment of toxoplasmic retinochoroiditis
21. Therapy of ocular toxoplasmosis
22. Quadruple therapy for ocular toxoplasmosis
23. Incidence of symptomatic toxoplasma eye disease: Aetiology and public health implications
24. Ocular involvement in toxoplasmosis
25. Ocular toxoplasmosis
26. Toxoplasmic chorioretinitis affecting the macula
27. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis
28. Atypical, severe toxoplasmic retinochoroiditis in elderly patients
29. Outbreak of toxoplasmosis in a family and documentation of acquired retinochoroiditis
30. Acquired toxoplasmosis
31. Acquired ocular toxoplasmosis-late onset
32. Toxoplasmose acquise àlocalisation oculaire ou neurologique. 49 Cas
33. Choriorétinite toxoplasmique acquise à révélation tardive
34. Long-term follow-up of patients with congenital ocular toxoplasmosis
35. Clinical appearance of toxoplasmic retinochoroiditis
36. Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth
37. Congenital human toxoplasmosis
38. Long term ocular and neurological involvement in severe congenital toxoplasmosis
39. Eye manifestations of congenital toxoplasmosis
40. Results of 20-year follow-up of congenital toxoplasmosis
41. Neurologic and developmental outcome in treated congenital toxoplasmosis
42. Retinal detachment in ocular toxoplasmosis
43. Presumed acquired ocular toxoplasmosis
44. Herdförmige iridocyclitis als (einzige) manifestation einer erworbenen toxoplasmose, ätiologisch gesichert durch titerkurve und tierversuch
45. Acquired toxoplasmic chorioretinitis
46. Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis
47. Intraocular inflammatory reactions without focal necrotizing retinochoroiditis, in patients with acquired systemic toxoplasmosis
48. Acute-unilateral toxoplasmic iridocyclitis in an AIDS patient
49. Indocyanine green angiography features in toxoplasmic retinochoroiditis
50. Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following treatment
51. Recurrence of treated toxoplasmic uveitis
52. Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis
53. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago Collaborative Treatment Trial
54. Definitive serological diagnosis of ocular toxoplasmosis